Variant report
Variant | nsv103185 |
---|---|
Chromosome Location | chr16:77249657-77252475 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:61)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | FOS | chr16:77250699-77250985 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | FOS | chr16:77250815-77250898 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | FOS | chr16:77250784-77250984 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | STAT3 | chr16:77250004-77250160 | MCF10A-Er-Src | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:77249973-77250023 | HCPEpiC | choroid plexus: | n/a |
2 | chr16:77249973-77250023 | HCF | heart: | n/a |
3 | chr16:77249973-77250023 | NB4 | blood: | n/a |
4 | chr16:77249973-77250023 | HMEC | breast: | n/a |
5 | chr16:77249973-77250023 | HRCEpiC | kidney: | n/a |
6 | chr16:77249973-77250023 | AG04449 | skin: | fetal |
7 | chr16:77249973-77250023 | SK-N-SH | brain: | n/a |
8 | chr16:77249973-77250023 | GM12878 | blood: | n/a |
9 | chr16:77249973-77250023 | Caco-2 | colon: | n/a |
10 | chr16:77249973-77250023 | PANC-1 | pancreas: | n/a |
11 | chr16:77249973-77250023 | Hela-S3 | cervix: | n/a |
12 | chr16:77249973-77250023 | SKMC | muscle: | n/a |
13 | chr16:77249973-77250023 | NT2-D1 | testis: | n/a |
14 | chr16:77249973-77250023 | HEEpiC | esophagus: | n/a |
15 | chr16:77249973-77250023 | NHDF-neo | bronchial: | n/a |
16 | chr16:77249973-77250023 | ProgFib | skin: | n/a |
17 | chr16:77249973-77250023 | HPAEpiC | pulmonary alveolar: | n/a |
18 | chr16:77249973-77250023 | NHBE | bronchial: | n/a |
19 | chr16:77249973-77250023 | IMR90 | lung: | fetal |
20 | chr16:77249973-77250023 | GM06990 | blood: | n/a |
21 | chr16:77249973-77250023 | HCT-116 | colon: | n/a |
22 | chr16:77249973-77250023 | H1-hESC | embryonic stem cell: | embryo |
23 | chr16:77249973-77250023 | BE2_C | brain: | n/a |
24 | chr16:77249973-77250023 | HAEpiC | amniotic membrane: | n/a |
25 | chr16:77249973-77250023 | BJ | skin: | n/a |
26 | chr16:77249973-77250023 | K562 | blood: | n/a |
27 | chr16:77249973-77250023 | AG10803 | skin: | n/a |
28 | chr16:77249973-77250023 | A549 | lung: | n/a |
29 | chr16:77249973-77250023 | HUVEC | blood vessel: | n/a |
30 | chr16:77249973-77250023 | AG04450 | lung: | fetal |
31 | chr16:77249973-77250023 | SAEC | small airway: | n/a |
32 | chr16:77249973-77250023 | ECC-1 | luminal epithelium: | n/a |
33 | chr16:77249973-77250023 | HCM | heart: | n/a |
34 | chr16:77249973-77250023 | GM12891 | blood: | n/a |
35 | chr16:77249973-77250023 | HEK293 | kidney: | embryo |
36 | chr16:77249973-77250023 | AG09309 | skin: | n/a |
37 | chr16:77249973-77250023 | Hepatocyte | liver: | n/a |
38 | chr16:77249973-77250023 | NH-A | brain: | n/a |
39 | chr16:77249973-77250023 | LNCaP | prostate: | n/a |
40 | chr16:77249973-77250023 | CMK | blood: | n/a |
41 | chr16:77249973-77250023 | RPTEC | kidney: | n/a |
42 | chr16:77249973-77250023 | GM12892 | blood: | n/a |
43 | chr16:77249973-77250023 | AG09319 | gingival: | n/a |
44 | chr16:77249973-77250023 | HL-60 | blood: | n/a |
45 | chr16:77249973-77250023 | ovcar-3 | ovarian: | n/a |
46 | chr16:77249973-77250023 | AoSMC | blood vessel: | n/a |
47 | chr16:77249973-77250023 | PrEC | prostate: | n/a |
48 | chr16:77249973-77250023 | MCF-7 | breast: | n/a |
49 | chr16:77249973-77250023 | U87 | brain: | n/a |
50 | chr16:77249973-77250023 | HIPEpiC | eye: | n/a |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:77240069..77243050-chr16:77247110..77249798,2 | MCF-7 | breast: | |
2 | chr16:77232724..77235283-chr16:77249460..77251454,2 | K562 | blood: | |
3 | chr16:77223216..77226884-chr16:77251990..77255920,6 | MCF-7 | breast: | |
4 | chr16:77247036..77249452-chr16:77252040..77253583,2 | K562 | blood: | |
5 | chr16:77251729..77253514-chr16:77255213..77256773,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
VN2R10P | TF binding region |
VN2R10P | CpG island |
ENSG00000205078 | chromatin interactions |
ENSG00000103111 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs532277260 | chr16:77249692-77249693 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs557061649 | chr16:77249708-77249709 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs377244478 | chr16:77249709-77249710 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs62049597 | chr16:77249742-77249743 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs567005213 | chr16:77249759-77249760 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs11149973 | chr16:77249784-77249785 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs35009015 | chr16:77249828-77249829 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs558816779 | chr16:77249836-77249837 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs574944299 | chr16:77249841-77249842 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs565718144 | chr16:77249854-77249855 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs139690637 | chr16:77249881-77249882 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs554683522 | chr16:77249886-77249887 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs113635594 | chr16:77249915-77249916 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs4888609 | chr16:77249919-77249920 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs540297403 | chr16:77249935-77249936 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs146381402 | chr16:77249940-77249941 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs189664063 | chr16:77249973-77249974 | Weak transcription Enhancers | CpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs546165766 | chr16:77249986-77249987 | Weak transcription Enhancers | CpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs182758097 | chr16:77249997-77249998 | Weak transcription Enhancers | CpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs530962649 | chr16:77250010-77250011 | Weak transcription Enhancers | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs550711796 | chr16:77250028-77250029 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs567620416 | chr16:77250037-77250038 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs534874540 | chr16:77250053-77250054 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs139718114 | chr16:77250072-77250073 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs116758808 | chr16:77250078-77250079 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs11639911 | chr16:77250095-77250096 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs573431999 | chr16:77250101-77250102 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs538846419 | chr16:77250117-77250118 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs114962421 | chr16:77250152-77250153 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs569195501 | chr16:77250153-77250154 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs538115525 | chr16:77250183-77250184 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs554290028 | chr16:77250187-77250188 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs144432166 | chr16:77250221-77250222 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs374902336 | chr16:77250282-77250283 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs539962029 | chr16:77250287-77250288 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs553827231 | chr16:77250305-77250306 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs577137921 | chr16:77250314-77250315 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs369535681 | chr16:77250318-77250319 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs562638486 | chr16:77250337-77250338 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs8048285 | chr16:77250399-77250400 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
41 | rs542058076 | chr16:77250419-77250420 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs536866854 | chr16:77250491-77250492 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs538729324 | chr16:77250529-77250530 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs79891434 | chr16:77250545-77250546 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | mRNA abundance |
45 | rs530098973 | chr16:77250579-77250580 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs546828563 | chr16:77250604-77250605 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs61032709 | chr16:77250608-77250609 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs372434666 | chr16:77250609-77250610 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs376460165 | chr16:77250625-77250626 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs569081744 | chr16:77250634-77250635 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 19156837 | CNVD |
Acute myeloid leukemia | 17377590 | CNVD |
Breast cancer | 20409316 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Lung cancer | 24585490 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20581869 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164919 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Melanoma | 17363583 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Colorectal cancer | 22860045 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:77247200-77250200 | Weak transcription | Primary hematopoietic stem cells | blood |
2 | chr16:77247200-77253600 | Weak transcription | Fetal Lung | lung |
3 | chr16:77247400-77254600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
4 | chr16:77247600-77251000 | Weak transcription | Fetal Stomach | stomach |
5 | chr16:77247600-77254400 | Weak transcription | Ovary | ovary |
6 | chr16:77247600-77257000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
7 | chr16:77247800-77250800 | Weak transcription | HSMMtube | muscle |
8 | chr16:77247800-77253600 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
9 | chr16:77247800-77257400 | Weak transcription | Esophagus | oesophagus |
10 | chr16:77247800-77261600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
11 | chr16:77248400-77251200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
12 | chr16:77248400-77253200 | Weak transcription | Hela-S3 | cervix |
13 | chr16:77248400-77256400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
14 | chr16:77248600-77250200 | Enhancers | A549 | lung |
15 | chr16:77248600-77253200 | Weak transcription | NH-A | brain |
16 | chr16:77248800-77253200 | Weak transcription | HUVEC | blood vessel |
17 | chr16:77248800-77254400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
18 | chr16:77248800-77256800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
19 | chr16:77248800-77257200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
20 | chr16:77248800-77262000 | Weak transcription | Fetal Muscle Trunk | muscle |
21 | chr16:77250200-77250400 | Flanking Active TSS | A549 | lung |
22 | chr16:77250400-77251200 | Enhancers | A549 | lung |
23 | chr16:77251200-77251400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
24 | chr16:77251200-77253000 | Weak transcription | A549 | lung |
25 | chr16:77251400-77251600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |